Study Finds Sudden Infant Deaths Have Increased
A new study published in the Journal of the American Medical Association (JAMA) last month has found that rates of Sudden Infant Death Syndrome (SIDS) increased 12 percent during 2020-2022, during the height of the coronavirus pandemic. SIDS is the unexplained death of an otherwise healthy infant, typically occurring in babies under one year old. […]
Antibiotics Largely Ineffective for Children in Asia-Pacific Region
A recent report published in The Lancet Regional Health–Southeast Asia from previously published studies found high levels of resistance to the antibiotics commonly used for empirical treatment of sepsis and meningitis in babies and children in the Asia-Pacific region.1 Researchers from the University of Sydney in Australia conducted this study to guide the empiric treatment […]
More Young Children Ingested Drugs and Illicit Substances During COVID Pandemic Period
A new study published in the Journal of the American Medical Association (JAMA) shows an increase in ingestion of illicit substances such as cannabis, opioids and ethanol among children under six years old in the COVID-19 pandemic period compared with the pre-pandemic period.1 “This is an important study, with a clear indication of the ongoing and […]
Shortage of Adderall Affecting Behavior in Children and Adults
On October 12, 2022, the U.S. Food and Drug Administration (FDA) announced a shortage of a drug formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall. Adderall is an FDA approved drug for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD), including anger, anxiety, forgetfulness and trouble focusing.1 Adderall […]
FDA Authorizes COVID Bivalent Shots for Children as Young as Five Years Old
On Oct. 12, 2022, the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) of the COVID bivalent booster versions of messenger RNA (mRNA) Comirnaty and Spikevax biologics developed by Pfizer/BioNTech and Moderna/NIAID for children as young as five or six years old, respectively. The FDA’s decision on Aug. 31 to grant […]
FDA, CDC Green Light Pfizer’s Experimental COVID Biologic for Children 5 to 11 Years Old
One Oct 29, 2021, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the experimental messenger RNA (mRNA) Pfizer/BioNTech COVID-19 biologic BNT162b2 for children five to 11 years old. The FDA’s decision, which is based on a clinical trial earlier this year involving 2,268 kindergartners and elementary school-aged kids and an […]